Here at Teva api, we’ve just published a brilliant new whitepaper on a very relevant and fascinating topic. The topic is complex generics and the experts who contributed to it are leading R&D scientists in our team. In the whitepaper, we deep-dive into two types of complex generics – respiratory and fermentation-based APIs.
The field of complex generics is steadily gaining momentum in the biopharma world. The advantage is double-fold: to increase the value for the end-patient by addressing unmet therapeutic needs, and simultaneously enable a company’s differentiation from others.
In this whitepaper, you’ll discover:
- Why the respiratory and fermentation segments are key for your portfolio
- The challenges associated with the development of respiratory and fermentation APIs
- What specialized skills and equipment are needed for development of these APIs
- How to remain competitive in 2022
Click below to download your copy of the whitepaper today!
